If mechanical clot-removal devices can improve the rates of opening arteries, it may be possible to avoid bad outcomes in patients with large artery strokes.
On February 11 2015, at the International Stroke Conference (ISC 2015 in Nashville, USA) the latest findings were released from four, large studies investigating the effect of treating patients with mechanical clo
MR CLEAN is a Dutch trial that investigated treatment of a severe form of ischaemic stroke (blockage type stroke) with thrombolysis alone (dissolving a clot with clot-busting drugs), versus treatment with both thrombolysis.
At present, it is not clear how best to organise NHS services so that patients can benefit from a thrombectomy for stroke.
Currently, a drug called alteplase is used in thrombolysis, but the researchers think that another drug, called tenecteplase, may be more effective than alteplase.
Two new research studies were published today, supporting the use of thrombectomy (mechanical retrieval of clots in the brain) for the treatment of large ischaemic strokes.
Two more studies support (thrombectomy) mechanical clot retrieval for stroke.
Exploring the effects of lowering blood pressure and a lower dose of clot busting drug on stroke outcome
Promising research results for a new drug treatment for ischaemic stroke patients have been published today in the journal ‘Lancet Neurology’.
Atrial fibrillation (AF) is a type of irregular heartbeat that can cause blood clots to form in your heart. Having atrial fibrillation increases your risk of stroke by five times.